US Drug Prices: A 2026 Moral Failure
US drug costs are 2-4x higher than other nations. Learn why this is a moral failure, what solutions exist, and what's next for policy.
US drug costs are 2-4x higher than other nations. Learn why this is a moral failure, what solutions exist, and what's next for policy.
Can gene-edited soybeans solve global food shortages? Learn how CRISPR improves crops, the regulatory hurdles, and early commercial uses.
Why bond yields remain high in 2026 and what central banks are doing. Learn how inflation and fiscal policy reshape your fixed-income strategy.
Iambic AI is drastically cutting drug development time, finding candidates in under a year. See how AI changes R&D and why it matters for new medicines.
PPI rose to 5.4%, signaling higher consumer prices ahead. Learn what this means for businesses, interest rates, and your budget.
Public Citizen wants drug price transparency by 2026. Learn why this matters for patient costs and how legislation like H.R. 783 could save billions.
Is reshoring a temporary fix or lasting shift for supply chains? See why over 70% of execs plan domestic growth by 2027 and its impact.
News paywalls in 2026: how AI and personalized content will change digital subscriptions. See why publishers must adapt to keep readers.
Iran loses billions to fuel smuggling. Why low prices fuel illicit trade, its impact on stability, and what's next for the crisis.
Global banks face a 2026 liquidity crunch. Understand why short-term funding is precarious, what risks this poses, and what to watch next.